L.A. and federal authorities arrested and filed indictments against India-based organized crime groups whose leaders are ...

The Indian government has strengthened oversight of cell and gene therapies by bringing the novel modalities into the ...

Thousands of bottles of a popular blood pressure medication have been recalled nationwide due to a potential manufacturing issue that may affect how well the drug works. According to the U.S. Food and ...

Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...

T he Drug Enforcement Administration plans to order emergency placements of 7-OH, cychlorphine and multiple substances ...

These are Class II recalls, meaning the affected bottles of medication may cause temporary and reversible effects.

Amgen recalled two common prescription medications, Corlanor and Sensipar, due to a potential foreign substance and quality ...

Over 11,0000 bottles of the blood pressure medication chlorthalidone have been recalled nationwide, according to the Food and Drug Administration (FDA). The FDA classified this as a Class II recall, ...

Washington — The Justice Department announced Thursday that it has issued an order rescheduling certain marijuana products to a lower drug classification, while moving to expedite the process to ...

(WJW) — Acting U.S. Attorney General Todd Blanche on Thursday, April 23, signed an order to reclassify state-licensed medical marijuana from the highest-regulated Schedule I drug classification to the ...